In this context, our study identifies Gnb5, a brain-enriched Gβ subunit of the GPCR complex, as a novel negative regulator of BACE1-mediated Aβ generation and a critical modulator of AD progression. This evidence concerns the gene GNB5 and Alzheimer disease.